Filing Flows › QuidelOrtho (QDEL) › Q3 2026 › vs Q2 2026
QuidelOrtho (QDEL) Q3 2026 vs Q2 2026 (quarter over quarter)
QuidelOrtho's revenue fell $12.0M (-2%) from $631M in Q2 2026 to $619M in Q3 2026.
QuidelOrtho, Q3 2026: revenue $619M (-12% year over year), operating margin -1.2%, net loss $53.8M, operating cash flow $19.6M. The chart draws each line against Q2 2026, the increases inside each band.
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $619M | $631M | −$12.0M | -2% |
| Income tax benefit | $9.1M | −$11.7M | $20.8M | — |
| Net loss | $53.8M | $92.9M | −$39.1M | -42% |
| Costs & expenses | $682M | $724M | −$42.0M | -6% |
| Operating costs | $626M | $653M | −$26.3M | -4% |
| Interest & other, net | $55.4M | $59.4M | −$4.0M | -7% |
| Cost of revenue | $329M | $358M | −$28.7M | -8% |
| Research & development | $42.5M | $48.7M | −$6.2M | -13% |
| SG&A | $183M | $190M | −$7.0M | -4% |
| Other operating costs | $71.9M | $56.3M | $15.6M | +28% |
| Operating cash sources | $132M | $129M | $2.9M | +2% |
| Depreciation & amortization | $120M | $117M | $2.9M | +2% |
| Share-based compensation | $12.0M | $12.0M | $0 | 0% |
| Net loss absorbed | $53.8M | $92.9M | −$39.1M | -42% |
| Working capital & other | $58.2M | $146M | −$88.2M | -60% |
| Operating cash flow | $19.6M | −$111M | $130M | — |
Questions
How much did QuidelOrtho's revenue grow quarter over quarter in Q3 2026?
QuidelOrtho's revenue fell $12.0M (-2%) from $631M in Q2 2026 to $619M in Q3 2026.